drugset / Trial / NCT01020955

Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)

NCT01020955

Phase 3 Completed 14 enrolled Karolinska University Hospital
RandomizedParallel-groupQuadruple-blind

Summary

The aim of this study is to measure effects of the combined treatment with GH and IGF-I on glucose sensitivity and body composition in patients with GHD and IGT or diabetes.

Timeline

Start
2009-10
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator mecasermin Protein / enzyme biologic 30 ug/kg
Comparator Somatropin Protein / enzyme biologic 0.3 mg